Reporting
Pilot project to implement a step-wise investigation that includes Cerebrospinal Fluid analysis as a standard of care for HIV+ individuals with cognitive symptoms
Learn MoreTerminated
An observational study of Kaletra®/Celsentri® combination therapy
Learn MoreCompleted
Phase III Study of AZT with Two Dose Levels of Intron-A in Treatment of AIDS-Related Kaposi's Sarcoma
Learn MoreCompleted
The impact of in-clinic follow-up with a sexologist on the sexual health of HIV-serodiscordant MSM couples
Learn MoreReporting
Penicillin therapeutic drug monitoring in the treatment of infectious syphilis. Do low serum penicillin concentrations correlate with treatment failure?
Learn MoreCompleted
A Prospective, Randomized Comparative Trial of Combination Chemotherapy of MAC Infection in AIDS: Trial results
Learn MoreCompleted
Counselling programme in combination with nicotine replacement therapy
Learn MoreCompleted
Renal monitoring in people living with HIV
Learn MoreCompleted
Role of extended-released niacin on immune activation in HIV-infected patients treated with antiretroviral therapy: a proof-of-concept study
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
